340B ACCESS Act
The 340B ACCESS Act strengthens oversight of the 340B Drug Pricing Program, which allows safety-net hospitals and clinics to purchase outpatient drugs at discounted prices. The bill clarifies who qualifies as a "patient" for 340B discounts, establishes new requirements for hospital child sites and contract pharmacies, and mandates that covered entities implement sliding fee scales to ensure patient affordability based on income. It creates a claims data clearinghouse to prevent duplicate Medicaid discounts and requires covered entities to report detailed data about drug dispensing. These changes aim to ensure 340B discounts reach intended patients while preventing program misuse and ensuring transparency.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 10, 2025
Last action Sep 10, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Sep 10, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Sep 10, 2025
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5256
Scope: US
Hi! I can help you understand HR 5256. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline